VHCP Management II’s KalVista Pharmaceuticals KALV Stock Holding History

VHCP Management II’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$6.52M	Sell	366,268 -10,621	-3%	-$139K	1.72%	7
2019 Q3	$4.37M	Hold	376,889	–	–	1.67%	14
2019 Q2	$8.35M	Sell	376,889 -196,593	-34%	-$4.61M	2.63%	11
2019 Q1	$16.4M	Sell	573,482 -185,699	-24%	-$4.03M	4.8%	8
2018 Q4	$15M	Hold	759,181	–	–	6.44%	7
2018 Q3	$16.8M	Buy	+759,181	New	+$10.3M	4.48%	8
2017 Q4	–	Sell	-221,651	Closed	-$1.49M	–	20
2017 Q3	$1.49M	Hold	221,651	–	–	0.41%	16
2017 Q2	$1.63M	Hold	221,651	–	–	0.65%	14
2017 Q1	$1.64M	Hold	221,651	–	–	0.67%	16
2016 Q4	$1.32M	Buy	+221,651	New	+$1.63M	0.63%	20

Other funds holding KALV

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

VHCP Management II's KALV Position: Q4 2019 in Review

VHCP Management II reduced its KalVista Pharmaceuticals (KALV) stake by 2.8% in Q4 2019, selling an estimated $139K and leaving 366,268 shares worth $6.52M. The position accounts for 1.72% of the portfolio, ranked #7.

VHCP Management II first reported a position in KALV in Q4 2016 and has held it in 10 quarters since. The position peaked at $16.8M in Q3 2018. 73 funds tracked by Wall St. Rank hold KALV as of Q4 2019.

VHCP Management II held 366,268 shares of KalVista Pharmaceuticals worth $6.52M as of Q4 2019.
VHCP Management II sold 10,621 KalVista Pharmaceuticals shares in Q4 2019, an estimated $139K.
KalVista Pharmaceuticals made up 1.72% of VHCP Management II's portfolio in Q4 2019, its #7 holding.
VHCP Management II first reported a position in KalVista Pharmaceuticals in Q4 2016 and has held it in 10 quarters since.
VHCP Management II's KalVista Pharmaceuticals position peaked at $16.8M in Q3 2018.
73 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q4 2019.

Based on VHCP Management II's 13F filing for Q4 2019, filed 13 Feb 2020.